Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

December 01, 2011 (Vol. 31, No. 21)

Emerging Trends for Predictive Toxicology

Novel Models Help Illuminate Safety Issues with Preclinical Drug Candidates

  • Protein therapeutics is still a relatively new class of drugs. Even after several highly successful market launches (e.g., Herceptin), our knowledge of protein drug distribution remains limited. Historically, development of protein therapeutics was geared toward candidates with the highest affinity to the target antigen or ligand. This, however, may ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.